Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bon, Y. Zhang, D. Zaldonis, A. Zeevi, K. McCurry, S. Greenspan, F. Sciurba (Pittsburgh, PA, United States Of America). Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease. Eur Respir J 2008; 32: Suppl. 52, 3007

Member's Comments

No comment yet.

Related content which might interest you: Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 688s Year: 2007 The effects of serum leptin on bone metabolism in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Loss of bone mineral density in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Primary care management of COPD Year: 2007 Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Role of the osteoprotegerin in the formation of osteopenic syndrome in chronic obstructive lung disease Source: Annual Congress 2008 - COPD Year: 2008 Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006 The role of inflamatory markers in obstructive pulmonary disease Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Peripheral lung remodelling in asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 893-894 Year: 2004 Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease? Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Blood MCP-1 levels are increased in chronic obstructive pulmonary disease with prevalent emphysema Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Clinical severity of chronic obstructive pulmonary disease is associated with bone mineral density Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Relationship between endothelial haemostatic markers in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004